Broad Resources
VC Fund
Shanghai, China
Broad Resources is a private equity fund manager.
- Total investments:
- 8
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Broad Resources invests in
Stages Broad Resources invests in
Countries Broad Resources invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Investment Focus
Industry
- Health Care 4 (50%)
- Medical 3 (38%)
- Biotechnology 3 (38%)
- Pharmaceutical 2 (25%)
- Hotel 1 (13%)
Stage
- Series A 3 (38%)
- Series C 2 (25%)
- Series B 1 (13%)
- Series D 1 (13%)
- Post-IPO Equity 1 (13%)
Country
- China 6 (75%)
- United States 1 (13%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Zhibin Hu
Founder
|
Founder | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
TenNor Therapeutics
|
TenNor Therapeutics is a clinical stage, product development company with a sharp focus on unmet medical needs in the area of infectious diseases. The company possesses a dual-acting drug discovery platform with several innovative products in various stages of preclinical and clinical development. The company is developing new drugs for thetreatment of Helicobacter pylori infections, prosthetic joint infections, multidrug-resistant Gram-negative infections and some other common and serious infectious diseases. | $9.5M / Series D / Dec 20, 2022 | |
Enpower Energy
|
Enpower Energy is a leading provider of battery energy storage solutions. | $15.8M / Series A / Mar 06, 2022 | |
JHOME
|
JHOME is a technology company that focuses on biological immune in vitro diagnosis, home medical electronics, and medical imaging. | $17M / Post-IPO Equity / Apr 16, 2018 | |
Suzhou Kintor Pharmaceuticals
|
Kintor founded in Suzhou in 2009, focusing on prostate cancer, breast cancer and liver cancer which account for more than 50% of the global cancer population and lack of effective treatment method. They have a product pipeline built on proprietary R&D and licensing arrangement, aiming to provide the best treatment plans for huge unmet patientneeds. They focus on developing a full R&D and commercialization platform for “best-in-class” and “first-in-class” novel drugs. | $44M / Series C / Jan 12, 2018 | |
lonwin
|
lonwin is a professional high-tech enterprise engaged in R&D, producing, maintenance, and service of medical imaging equipment. | $4.3M / Series C / Nov 15, 2017 | |
MIUTRIP.COM
|
MIUTRIP.COM provides IT solutions for travel, hotel, passenger transportation and insurance industries. | $2.8M / Series B / May 10, 2016 | |
ykyao.com
|
ykyao.com provides pharmaceutical e-commerce enterprises integrating online pharmacies, high-end chains & professional pharmacist services. | $14.2M / Series A / Mar 08, 2016 | |
|
MIUTRIP.COM
|
MIUTRIP.COM provides IT solutions for travel, hotel, passenger transportation and insurance industries. | $1.3M / Series A / Aug 27, 2015 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Broad Resources invest in?
Broad Resources invests primarily in Health Care, Medical and Biotechnology startups, most often at Series A and Series C stage. Most of the 8 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Broad Resources?
Public channels for Broad Resources include the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Broad Resources?
The team at Broad Resources includes Zhibin Hu (Founder). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
